Ancillary Revenue Program - Are you still sending out these tests to an outside lab? UTI/STI • Vaginitis • Respiratory • ENT/Sinus • Wound • GI related infections. Find out how to CAPTURE OUTSIDE LAB REVENUE and improve patient experience and outcomes. (8) tests a day generates you over $30K in bottom-line revenue & advances patient care with a 1-hour test result that includes antibiotic resistance read-out.
https://optimalhealthadvocates.com/
UROLOGY • OB/GYN • INTERNAL MEDICINE • PRIMARY CARE • URGENT CARE • PEDIATRICS • ENT/ALLERGY • WOUND CARE
PROVEN PROGRAM:
✅ Over 100 Established Locations across the United States -- each generating at least $30K/month in bottom-line revenue.
✅ ELIMINATE delayed or ineffective antibiotic treatment & costly last-minute surgery cancellations (1-hour turn-around for results with antibiotic resistance read-out);
✅ Keep your providers compliant with CDC Antibiotic Stewardship Program (that is soon to be mandated in the clinical setting) with our program's monthly reports that will increase your facility health score by showing you are reducing the use of unnecessary antibiotics with PCR testing that is 96% more accurate than a traditional culture.
We handle ALL of the upfront capital costs, billing, staffing, and CLIA licensure/compliance at NO UPFRONT COST TO THE PRACTICE -- All that’s required is a 6-foot workspace to run the tests.
To LEARN MORE and SEE IF YOUR PRACTICE QUALIFIES, Book a 10-min Discovery Call with Jen here:
https://go.oncehub.com/Advanced_In-Office_PCR_Lab_Discovery-Call
Optimal Health Advocates as an Ancillary Medical Practice Revenue Generation company helping medical practices capture significant revenue increases while improving patient lives and outcomes.
--------------
Jennifer Anderson is a 20-year Practice Manager, entrepreneur, and digital marketing expert who intimately understands the challenges of the business of medicine and is passionate about helping Medical Sales Companies and Medical Practices successfully implement systems and services that enhance and save patient lives and increase practice revenue.
Call Girls in Lucknow Just Call 👉👉8630512678 Top Class Call Girl Service Avai...
Advanced In-Office 1-hour PCR LAB - Ancillary Revenue Program
1. Advanced In-Office
PCR Testing Program
UTI • Respiratory • Sinus • Vaginitis •
Wound Care • Gastroenterology
Ancillary Revenue Opportunity
2. www.optimalhealthadvocates.com
2
The Integration of this
system will grant you billing
privileges and the control of
your patient’s financial
outcome.
IN-OFFICE POINT-OF-CARE PCR TESTING
= RAPIDLY INCREASED MONTHLY REVENUE
Our Point of Care Joint
Venture Program is
revolutionizing the way
medical practices increase
monthly revenue.
Most practices are still using off-
site laboratories to process their
patients Urinary & Respiratory
Tract related cultures. Often
these facilities are not only
billing the insurance carrier, they
also send patients to collections.
3. www.optimalhealthadvocates.com
3
TESTING BENEFITS
Test your patients in-office and get
test results during the same visit,
while traditional culture & sensitivity
tests take 24-72 hours to get results.
ELIMINATE costly last-minute surgery
cancellations due to untreated UTI or
other infection positive/untreated
results.
1-Hour Test Results
Test results will provide the antibiotic
resistance of the organism that
presents as positive in your patients
test results.
Know for sure that you are
prescribing the most effective
antibiotic for your patient.
Antibiotic Resistance Read-Out
By integrating the point-of-care
system into your office. Your medical
practice will elevate with robust
services, increased treatment
capabilities, and monthly revenue.
Test your patients on a clinical
level just like the Laboratories.
We have designed this program to be
effortless on your part.
WE PROVIDE:
• The Setup (including your CLIA license)
• The Device
• The Technician
• The Supplies
• The Billing
The Joint Venture program is a
complete turnkey opportunity. The CDC has started to mandate the use of antibiotic alternatives for long-term
managed care. By reducing the use of antibiotics patients will have less resistance when
it is truly needed.
We have created a program that keeps you compliant with monthly reports. PCR testing
will help reduce the use of antibiotics and increase your facility health score. It is only a
matter of time before it is mandated at the clinical level.
Compliant with CDC’s Antibiotic Stewardship Program
4. www.microbiodx.com ‹#›
Test results indicate within 1 hour whether
a patient requires antibiotics, thereby
affirming a provider’s decision to treat and
select the appropriate course of antibiotics,
avoiding unnecessary antibiotic treatments,
quarantine, and isolation procedures.
“Patients can be tested quickly, in-
office, prior to surgery, avoiding
costly surgery cancellations.”
“Early detection can effectively
minimize transmission of infection,
thereby preventing or more quickly
bringing an outbreak under control.”
5. www.microbiodx.com ‹#›
Advanced PCR Technology
➔ Rapid test results in under 1-hour
➔ 96% more accurate than
traditional culture testing.
(Identifies MORE bacteria than
traditional urine culture and is able to
detect more fastidious bacteria)
➔ CDC Guidelines - “If an important
clinical decision is affected by the test
result, the [Rapid influenza test kits]
result should be confirmed by a
molecular assay, such as reverse
transcription polymerase chain reaction
(RTPCR).” -CDC on Rapid Influenza Test
Kits (RIDTs)
➔ The test is unaffected by the use
of antibiotics.
Why use PCR Technology?
RPP (Respiratory Panel Testing) is a
qualitative test that will identify DNA
from respiratory viruses and bacteria
extracted from nasopharyngeal swabs
from individuals with clinical signs and
symptoms of a respiratory tract
infection. This panel employs PCR
(Polymerase Chain Reaction)
technology which is used to “amplify”
small quantities of nucleic acid into
detectable levels which leads to more
accurate results.
What is Respiratory Panel
Testing?
UTI (Urinary Tract Infection) testing
utilizes quantitative PCR (Polymerase
Chain Reaction) technology to rapidly
analyze your patient’s sample. PCR
technology precisely detects the correct
pathogen(s) and identifies antibiotic
drug resistance. This allows providers
the ability to prescribe timely and
effective treatment.
What Is Urinary Tract
Infection Testing?
6. www.optimalhealthadvocates.com
6
What does this mean for Your Practice?
Increased Clinical
Value
100%
Over-prescription of
Antibiotics
0%
Timely, actionable
results
45 MINUTES
Stop guessing and
start treating
IMMEDIATELY
No upfront cost
$0.00
SUCCESS
Just eight (8) tests a day can generate over $30K+ per month in bottom-line revenue
7. www.optimalhealthadvocates.com
7
How Does the Joint Venture Work?
We provide all the following at zero cost for you.
Daily Revenue (8) samples per day X
$620.00
=
$4,960.00
Avg. Reimbursement per patient Daily revenue
Monthly Revenue $4960.00 Daily X
22
=
$109,120.00
Working days per month Monthly revenue
Cost to run
program daily
$265.00 per test daily
(Includes reagents, Tech,
billing, prior auth, software,
supplies, etc.)
X
8
=
$2,120
Tests per day Cost to run program daily
Cost to run
program monthly
$2,120.00 Daily X
22
=
$46,640
Working days per month Monthly cost to run program daily
Net revenue
Monthly revenue
$109,120.00 (Prior to
expenses)
-$46,640.00 $62,480.00
(Monthly expenses) Net revenue to the program
Your investment
cost = $0.00
50/50 Revenue Split Practice Monthly Revenue = $31,240.00
This complete turn-key system
is a lucrative opportunity for
your medical practice.
Our team gets you completely
setup.
Your office will never miss a
beat, from CLIA site certification
to training we will ensure that
your Point-Of-Care service is
ready for immediate use.
Custom Insurance Pro
Forma evaluation
FREE
CLIA Waived License
FREE
Dedicated On-site
Technician
FREE
Point-Of-Care
Testing Device
FREE
All-inclusive Billing
FREE
Contact: Jennifer Anderson
(775) 846-8293 (mobile)
jen@optimalhealthadvocates.com
7
8. www.optimalhealthadvocates.com
8
In-Office Testing Device
The program requires 6 feet of dedicated desk space and a CLIA Certificate.
CLIA licensure and ongoing compliance is part of the program and does not require any upfront costs.
Integrate the Point-Of-Care
testing device today
Increase your
monthly revenue with
no out-of-pocket expenses
Our well-known manufacturer provides hardware
for laboratories and hospitals nationwide.
9. www.optimalhealthadvocates.com
9
The Impact of UTI’s and RPP’s on Humanity
and the Healthcare System
~10 Million
Office Visits
per Year
23,000
Deaths
$13 Billion in
Costs
01 02 03
Up to 1/3 of all infections illustrate
resistance to antibiotics
Complications from UTI’s results in
9-11 days longer for each hospital
stay
Candida Albicans ⧫ Chlamydia Trachomatis ⧫ Neisseria Gonorrhoeae ⧫ Streptococcus agalactiae ⧫ Streptococcus pyogenes (Group B) ⧫ Trichomonas Vaginalis ⧫ Gardnerella vaginalis
⧫ Staphylococcus Aureus ⧫ MRSA (Methicillin resistance) ⧫ Staphylococcus saprophyticus serratia marcescens ⧫ Proteus Mirabilis ⧫ Klebsiella Pneumoniae/ Oxytoca ⧫ Acinetobacter
Baumannii ⧫ Citrobacter Freundii/Braakii ⧫ Escherichia Coli ⧫ Pseudomonas Aeruginosa ⧫ Enterococcus Faecium ⧫ Citrobacter Koseri ⧫ Class A B-lactamase; Blakpc ⧫ Class A B-
lactamase; Ctx-m Group 1 ⧫ Class B Metallo-b -Lactamase; Blandm ⧫ Vancomycin-resistant enterococci; VanA ⧫ DNA/RNA Amplified Probe
UTI Pathogen Panel
10. www.optimalhealthadvocates.com
10
It has been estimated each
year in the United States
the flu result in:
RESPIRATORY
BURDEN
31.4 Million
Outpatient Visits
About 200,000
Hospitalization
More than $87 Billion
in Total Economic
Burden
Between 3,000 to
49,000 Deaths
Influenza virus, (A & B) ⧫ Human metapneumovirus (A & B) ⧫ Rhinovirus species (A & B) ⧫ Adenovirus species ⧫ Parainfluenza virus species (type 1-4) ⧫ Coronavirus species
(229E, HKU1, NL63, OC43) ⧫ Legionella Pneumophila ⧫ Mycoplasma Pneumoniae ⧫ Chlamydia Pneumoniae ⧫ Streptococcus, Group A ⧫ RSV, (A & B) ⧫ Enterovirus species ⧫
Staphylococcus aureus ⧫ Haemophilus Influenzae ⧫ Moraxella catarrhalis ⧫ Streptococcus pneumoniae ⧫ Bordetella pertussis ⧫ Staphylococcus epidermidis ⧫ Klebsiella
pneumoniae ⧫ MRSA ⧫ Pneumocystis jirovecii ⧫ Coxiella Burnetii Antimicrobial Resistant Genes ⧫ VIM ⧫ CTX-M
RPP Pathogen Panel
11. www.optimalhealthadvocates.com
11
The Process
➔Complete Practice Pre-
Qualification Application
➔Schedule Call to Review
CPT codes
➔Receive Approval Letter &
Custom Proforma for your
Practice
➔Schedule meeting to
review Pro Forma & Next
Steps
➔Review Proforma with
Practice
➔Agreement and Credit
App Signatures
➔Schedule Licensing,
Validation, and
Implementation dates
➔Schedule Implementation
meeting
➔Onsite CLIA Licensing
and Validation
➔Onsite Implementation
Running Tests
Any questions please contact your Account Executive.
Day
30
Pre-Qualify